Abstract
Safety and Efficacy of Ibrutinib in Combination with Venetoclax in Patients with Marginal Zone Lymphoma: Preliminary Results from an Open Label, Phase II Study
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have